Clinical Trial Update: S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating hormone therapy with or without mitoxantrone and prednisone in patients after radical prostatectomy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Mitoxantrone (mitoxantrone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-09-04